Latest: FDA Approves New Biosimilar for Oncology Treatment

STAT+: As mRNA falls out of favor for HHS, are cancer vaccines next?

0 Mins
Cancer vaccines in development rely on mRNA technology under attack by RFK Jr. “I am concerned that this could bleed over," an oncologist says.
Tags:
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago